Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,141,608
+$59,709 QoQ
Shares Held
12,370
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,976
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Berkeley Capital Partners, LLC holds $14,092,981 across 9 Drug Manufacturers - General names. JNJ ranks #1 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
12,370 | $3,141,608 | |
| 2 | MRK |
Merck & Co., Inc.
|
17,441 | $2,241,168 | |
| 3 | ABBV |
AbbVie Inc.
|
7,720 | $1,942,660 | |
| 4 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 | |
| 5 | NVS |
Novartis AG
|
10,041 | $1,573,625 | |
| 6 | PFE |
Pfizer Inc
|
64,286 | $1,548,006 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,331 | $1,459,572 | |
| 8 | NVO |
Novo Nordisk A S
|
6,115 | $293,153 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,141,608 | 12,370 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,081,899 | 12,608 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,679,606 | 8,116 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,272,352 | 6,862 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,027,702 | 6,728 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,145,291 | 6,906 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $971,701 | 6,719 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,153,056 | 7,115 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $960,855 | 6,574 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $987,105 | 6,240 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $962,383 | 6,140 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $990,414 | 6,359 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,150,932 | 12,995 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,878,755 | 12,121 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,097,718 | 11,875 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,873,249 | 11,467 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,174,051 | 6,614 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,152,881 | 6,505 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,109,902 | 6,488 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $978,044 | 6,056 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $952,032 | 5,779 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $947,970 | 5,768 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,055,705 | 6,708 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,096,947 | 7,368 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $920,985 | 6,549 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,062,677 | 8,104 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||